Experienced in Major Depression

Dr. Jelena L. Kunovac

Psychiatry
3012 W Charleston Blvd Ste 100, 
Las Vegas, NV 
Experienced in Major Depression
3012 W Charleston Blvd Ste 100, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jelena Kunovac is a Psychiatrist in Las Vegas, Nevada. Dr. Kunovac is rated as an Experienced provider by MediFind in the treatment of Major Depression. Her top areas of expertise are Schizophrenia, Major Depression, and Attention Deficit Hyperactivity Disorder (ADHD).

Her clinical research consists of co-authoring 7 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles and participated in 1 clinical trial in the study of Major Depression.

Specialties
Psychiatry
Licenses
Psychiatry & Neurology in NV
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO

Locations

3012 W Charleston Blvd Ste 100, Las Vegas, NV 89102

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
Enrollment Status: Terminated
Publish Date: October 04, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drug: SPN-812
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: July 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
View 5 Less Clinical Trials

7 Total Publications

A Phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder.
A Phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder.
Journal: Current medical research and opinion
Published: October 16, 2025
Similar Doctors
Distinguished in Major Depression
Dr. David E. Linden
Psychiatry | Pain Medicine
Distinguished in Major Depression
Dr. David E. Linden
Psychiatry | Pain Medicine

Silver State Health Care Services LLC

2725 S Jones Blvd, Suite 104, 
Las Vegas, NV 
 (2.8 miles away)
702-384-2238
Experience:
44+ years
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Linden is a Psychiatrist and a Pain Medicine provider in Las Vegas, Nevada. Dr. Linden has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Major Depression. His top areas of expertise are Vascular Dementia, Schizoaffective Disorder, Major Depression, and Schizophrenia. Dr. Linden is currently accepting new patients.

Distinguished in Major Depression
Dr. Alex V. Delrosario
Psychiatry
Distinguished in Major Depression
Dr. Alex V. Delrosario
Psychiatry

State Of Nevada

6161 W Charleston Blvd, 
Las Vegas, NV 
 (2.5 miles away)
702-486-6045
Languages Spoken:
English, Filipino, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Alex Delrosario is a Psychiatrist in Las Vegas, Nevada. Dr. Delrosario is rated as an Advanced provider by MediFind in the treatment of Major Depression. His top areas of expertise are Bipolar Disorder (BPD), Major Depression, Seasonal Affective Disorder (SAD), and Schizoaffective Disorder. Dr. Delrosario is currently accepting new patients.

Distinguished in Major Depression
Dr. Uzma N. Zafar
Psychiatry
Distinguished in Major Depression
Dr. Uzma N. Zafar
Psychiatry

Uzma Zafar MD PC

5536 S Fort Apache Rd, Suite 102, 
Las Vegas, NV 
 (8.1 miles away)
725-666-1636
Languages Spoken:
English, Arabic, Punjabi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Uzma Zafar is a Psychiatrist in Las Vegas, Nevada. Dr. Zafar is rated as a Distinguished provider by MediFind in the treatment of Major Depression. Her top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizophrenia, and Obsessive-Compulsive Disorder (OCD). Dr. Zafar is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kunovac's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile